The European Medicines Agency (EMA) said on Thursday that it had started evaluating the use of Moderna's vaccine against Covid-19 in children between 6 months and 5 years old, the last age group not yet known. can be vaccinated.
A first request in the USA
“We have just begun the evaluation of a request from Moderna to expand the use of Spikevax to children six months to five years old, and this is the first request for this young age group,” said during the presentation. a press conference Marco Cavaleri, head of vaccine strategy at the EMA.
American biotech company Moderna already made a similar request in the United States last week after trials showed its injections were safe and produced a strong immune response.
Less vulnerable young people
Young children are less vulnerable to the virus than older people, but they can still get sick and transmit the virus.
They can also contract severe cases of pediatric multisystem inflammatory syndrome (MIS-C).
In February, the EMA approved the use of Moderna's Covid vaccine for children aged six and over in the 27 countries of the European Union.
Covid-19: Moderna requests authorization of its vaccine for children under 6 in the United States
Covid-19: Pfizer's turnover jumps thanks to the anti-Covid-19 vaccine